Jeffrey D. Yingling
About
In The Last Decade
Jeffrey D. Yingling
14 papers receiving 438 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 168
- Cardiology and Cardiovascular Medicine 151
- Biomedical Engineering 79
- Ophthalmology 69
- Oncology 35
Countries citing papers authored by Jeffrey D. Yingling
This map shows the geographic impact of Jeffrey D. Yingling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Yingling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Yingling more than expected).
Fields of papers citing papers by Jeffrey D. Yingling
This network shows the impact of papers produced by Jeffrey D. Yingling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Yingling. The network helps show where Jeffrey D. Yingling may publish in the future.
Co-authorship network of co-authors of Jeffrey D. Yingling
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Yingling. A scholar is included among the top collaborators of Jeffrey D. Yingling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Yingling. Jeffrey D. Yingling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 82 | |
| 2 | IOP-lowering Efficacy And Tolerability Of AR-13324, A Dual Mechanism Kinase Inhibitor For The Treatment Of Glaucoma | 3 |
| 3 | IOP-Lowering Efficacy and Tolerability of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma | 3 |
| 4 | Discovery and in vitro SAR of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma | 8 |
| 5 | 37 | |
| 6 | 105 | |
| 7 | 14 | |
| 8 | 18 | |
| 9 | 6 | |
| 10 | 8 | |
| 11 | 26 | |
| 12 | 115 | |
| 13 | 9 | |
| 14 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.